Management of Chronic Inflammatory Conditions
Duralactin Canine is an immuno-nutritional aid for the
management of chronic inflammatory and musculoskeletal conditions, skin
allergies, stomatitis, inflammatory bowel disease, and bladder
infections in dogs.
Duralactin Canine contains a patented dried milk protein
concentrate derived from hyper-immunized cows and is believed to help manage
long term inflammatory conditions, and can help diminish the need for steroids
or NSAIDs.
Arthritis in dogs is an inflammatory condition and can
be an extremely painful condition. There is no cure for dog arthritis, so a plan
for long-term pain management is needed. Duralactin Canine can be used alone, or
as a supplement to other treatment options. Duralactin products are all-natural and does
not interfere with the use of NSAIDs (non-steroidal anti-inflammatory drugs),
corticosteroids, glucosamine, or other medications or supplements.
Duralactin's MicroLactin contains factors that appear to
block and inhibit body chemicals from participating in the inflammatory response
of cat arthritis. Daily use may significantly diminish the pain felt by an
arthritic or chronically ill dog.
- Non-prescription
- Helps support normal activity and wellness
- All natural
- Vanilla-flavored chewable tablets
Active Ingredients chewable tablet:
Directions for use:
Feed directly or give with food.
Weight of Dog |
Dosage |
Up to 40 lbs |
1/2 tablet twice daily |
40-80 lbs |
1 tablet twice daily |
Over 80 lbs |
1-1/2 tablets twice daily |
Signs of improvement will usually occur about 1 to 2
weeks after beginning the Duralactin treatment. You may notice a
significant improvement in the ability to go up and down stairs, or moving about. Some
dogs will return to jumping,
running and playing as normal in a relatively short period of time.
Caution: Some pets may be
sensitive to milk proteins and/or carbohydrates. If vomiting or diarrhea
occurs, discontinue the use of Duralactin and contact your veterinarian.
For use in dogs only.
Storage: Room temperature.
Keep out of reach of children.